An Open-label, Single-Arm, Phase 2 Study of Carfilzomib Maintenance Therapy

An Open-label, Single-Arm, Phase 2 Study of Carfilzomib Maintenance Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols

Sponsor(s)

Proteolix

Principal Investigator(s)Jonathan L Kaufman, MD
Dates9/09/2009 - 9/08/2013